Experimental leukaemia vaccine shows promise in clinical trial
An experimental vaccine for acute myeloid leukaemia has helped patients in remission live significantly longer by training the immune system to target cancer cells. While the data awaits peer review, the results suggest a potential new treatment path for those facing limited options after the disease returns.
Source: Positive.News
National
Read the full story